PELIZZA, LORENZO
 Distribuzione geografica
Continente #
AS - Asia 4.218
EU - Europa 1.893
NA - Nord America 1.341
SA - Sud America 255
AF - Africa 123
OC - Oceania 31
Totale 7.861
Nazione #
SG - Singapore 1.365
CN - Cina 1.330
US - Stati Uniti d'America 1.300
IT - Italia 1.253
HK - Hong Kong 484
VN - Vietnam 403
KR - Corea 296
BR - Brasile 177
NL - Olanda 125
DE - Germania 120
JO - Giordania 100
GB - Regno Unito 79
IN - India 79
FR - Francia 77
SC - Seychelles 74
JP - Giappone 56
SE - Svezia 48
FI - Finlandia 47
IE - Irlanda 38
AR - Argentina 34
AU - Australia 29
AT - Austria 23
RU - Federazione Russa 23
CA - Canada 22
ID - Indonesia 22
EC - Ecuador 18
MX - Messico 17
CI - Costa d'Avorio 13
PL - Polonia 13
BD - Bangladesh 12
ES - Italia 11
ZA - Sudafrica 11
TW - Taiwan 10
CH - Svizzera 9
IR - Iran 9
KZ - Kazakistan 9
TR - Turchia 9
EG - Egitto 8
MY - Malesia 8
CL - Cile 7
LT - Lituania 7
IL - Israele 6
PE - Perù 5
PY - Paraguay 5
NO - Norvegia 4
TN - Tunisia 4
VE - Venezuela 4
AZ - Azerbaigian 3
BE - Belgio 3
CO - Colombia 3
DZ - Algeria 3
HR - Croazia 3
SA - Arabia Saudita 3
UA - Ucraina 3
AE - Emirati Arabi Uniti 2
GE - Georgia 2
KE - Kenya 2
MA - Marocco 2
NZ - Nuova Zelanda 2
QA - Qatar 2
UY - Uruguay 2
UZ - Uzbekistan 2
ZW - Zimbabwe 2
AL - Albania 1
AO - Angola 1
BG - Bulgaria 1
BW - Botswana 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
GR - Grecia 1
GT - Guatemala 1
IQ - Iraq 1
LB - Libano 1
LV - Lettonia 1
MN - Mongolia 1
NG - Nigeria 1
NP - Nepal 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
RO - Romania 1
SD - Sudan 1
Totale 7.861
Città #
Singapore 857
Hefei 705
Hong Kong 481
Santa Clara 320
Seoul 294
Bologna 240
Ashburn 213
Boardman 155
Milan 136
Ho Chi Minh City 126
Hanoi 119
Amman 100
Beijing 84
Bengaluru 66
Rome 66
Los Angeles 50
Dallas 49
Tokyo 48
Castel Maggiore 37
Dublin 37
Turin 37
Frankfurt am Main 35
Verona 33
Nuremberg 27
Florence 26
Naples 26
Parma 25
Redondo Beach 25
Buffalo 24
Modena 24
New York 24
Chicago 22
Helsinki 22
Reggio Emilia 19
Shanghai 18
Tongling 18
Fort Worth 17
Falkenstein 16
Lappeenranta 16
Munich 16
Da Nang 15
Desio 15
Sydney 15
Quarrata 14
Rancho Palos Verdes 14
Springfield 14
Abidjan 13
Biên Hòa 13
Brooklyn 13
Genoa 13
Guangzhou 13
Jakarta 13
São Paulo 13
Xi'an 13
Bari 12
Cesena 12
Cologne 12
Stockholm 12
Melbourne 11
Council Bluffs 10
Quận Bình Thạnh 10
Salt Lake City 10
Seattle 10
Shenzhen 10
Toronto 10
Amsterdam 9
Mexico City 9
Minerbio 9
Taranto 9
Wuhan 9
Catania 8
Ferrara 8
Haiphong 8
Manchester 8
Orem 8
Zhengzhou 8
Bern 7
Columbus 7
Curitiba 7
Foshan 7
Guayaquil 7
Montreal 7
Prineville 7
Roubaix 7
Turku 7
Vienna 7
Glasgow 6
Johannesburg 6
London 6
Macerata 6
Ninh Bình 6
Norwich 6
Palermo 6
Petropavl 6
Qingdao 6
Rio de Janeiro 6
Bexley 5
Brescia 5
Denver 5
Hangzhou 5
Totale 5.206
Nome #
Proprietà psicometriche della Scala di Parma: un nuovo strumento per la valutazione dei trattamenti sui pazienti psichiatrici autori di reato. 328
Reliability of the Italian version of the 16-item Prodromal Questionnaire (iPQ-16) for psychosis risk screening in a young help-seeking community sample 197
Borderline personality disorder and aggressive behavior: A study based on the DSM-5 alternative model. 183
Antipsychotic medication in individuals at Clinical High Risk for Psychosis: what recommendations for clinicians? 161
Borderline personality disorder vs. schizophrenia spectrum disorders: clinical comparisons in young people treated within an “Early Intervention” service for first episode psychosis. 152
Patterns of antipsychotic prescription and accelerometer-based physical activity levels in people with schizophrenia spectrum disorders: a multicenter, prospective study 134
A public early intervention approach to first-episode psychosis: treated incidence over 7 years in the Emilia-Romagna region. 133
Presentation of the “Parma Scale” for treatment evaluation in offenders with mental disorders 129
Diagnostic shift in adolescents with first episode psychosis: findings from the 2-year follow-up of the “Parma Early Psychosis” program. 124
Diagnostic shift in first episode psychosis: Results from the 2-year follow-up of the “Parma Early Psychosis” program. 119
Clinical High-Risk for Psychosis (CHR-P) circa 2024: synoptic analysis and synthesis of contemporary treatment guidelines. 118
Dissociation and dysfunctional personality traits in patients with borderline personality disorder: A study based On DSM-5 alternative model 118
Disorganization in individuals at clinical high risk for psychosis: psychopathology and treatment response. 116
Borderline personality disorder and early psychosis: a narrative review. 114
Persistent negative symptoms in young people at clinical high risk of psychosis treated with an Italian early intervention program: a longitudinal study 113
Autism characteristics in young patients with first episode of schizophrenia spectrum disorder: findings from a 2-year longitudinal research 113
Obsessive-compulsive symptoms in individuals at clinical high risk for psychosis: A 2-year longitudinal study 113
Psychiatric antecedents in young patients with first episode psychosis: what relevance for clinical outcomes? 110
Anhedonia and suicidal ideation in young people with early psychosis: Further findings from the 2-year follow-up of the ReARMS program. 110
Is depressed mood clinically relevant at the onset of schizophrenia? A longitudinal study. 107
Familiarity for Serious Mental Illness in Help-Seeking Adolescents at Clinical High Risk of Psychosis 106
Psychological screening service for newly-admitted inmates in the Parma Penitentiary Institutes: process analysis after 1 year of clinical activity. 105
La psicoterapia individuale può ridurre l’ideazione suicidaria in giovani con primo episodio di psicosi? Dati dal mondo reale. 100
The Italian version of the 16-item prodromal questionnaire (iPQ-16): Field-test and psychometric features 99
Unfavorable short-term outcome indicators in young people at clinical high risk for psychosis: preliminary results from the “Parma At-Risk Mental States” (PARMS) program. 97
Compulsory treatment across a 2-year follow-up within an “Early Intervention in Psychosis” program in Italy: Incidence rates and baseline predictors. 97
Sex comparisons on the benefcial efects of an early intervention program in a patients’ cohort with frst episode psychosis: what effectiveness in women? 95
Sociodemographic and clinical characteristics of patients with borderline personality disorder enrolled for a first episode psychosis within a specialized “early intervention” service. 95
Rates and predictors of service disengagement in adolescents with first episode psychosis: results from the 2‑year follow‑up of the Pr‑EP program. 94
Assessing aberrant salience in young community help-seekers with early psychosis: The approved Italian version of the Aberrant Salience Inventory 93
Short‑term disengagement from early intervention service for first‑episode psychosis: findings from the “Parma Early Psychosis” program. 92
Sleep disturbances in individuals with first episode psychosis and clinical high-risk states: A systematic review 92
Compulsory admission as access to early intervention service for patients with first episode psychosis: What relevance for clinical outcomes? Further findings from the Pr-EP program. 91
DEPRESSIVE FEATURES IN INDIVIDUALS WITH FIRST EPISODE PSYCHOSIS: PSYCHOPATHOLOGICAL AND TREATMENT CONSIDERATIONS FROM A 2-YEAR FOLLOW-UP STUDY 91
Rates and predictors of service disengagement in first episode psychosis: Results from a 2-year follow-up study in an Italian real-world care setting 89
What autism features in first episode psychosis? Results from a 2‑year follow‑up study. 89
Sex differences in schizophrenia spectrum disorders: insights from the DiAPAson study using a data-driven approach 86
Cognitive disturbances basic symptoms in help-seeking patients with borderline personality disorder: Characteristics and association with schizotypy. 86
Interrater reliability of the authorized Italian version of the Comprehensive Assessment of At-Risk Mental States (CAARMS-ITA) 86
Looking at Intergenerational Risk Factors in Schizophrenia Spectrum Disorders: New Frontiers for Early Vulnerability Identification? 83
Individual psychotherapy may help to reduce suicidal ideation in first episode psychosis: results from a 2-year Italian follow-up study 76
Patients’ Experience on a Supportive Group Therapy in an Italian Psychiatric Residential Facility During the COVID-19 Pandemic 74
Autism-spectrum traits in First Episode Psychosis: Psychopathological and prognostic considerations from a 2-year follow-up study. 69
Implementation of Individual Placement and Support in Italy: The Reggio Emilia Experience 67
Clinical high risk for psychosis and service disengagement: Incidence and predictors across 2 years of follow-up 64
Phenomenological psychopathology meets machine learning: A multicentric retrospective study (Mu.St.A.R.D.) targeting the role of Aberrant Salience assessment in psychosis detection. 58
Borderline personality disorder vs. schizophrenia spectrum disorders in young people recruited within an “Early Intervention in Psychosis” service: clinical and outcome comparisons. 58
Antipsychotic Treatment in People at Clinical High Risk for Psychosis A Narrative Review of Suggestions for Clinical Practice 55
Baseline Exposure to Antipsychotic Medication in Young People at Clinical High Risk for Psychosis: A 2‐Year Italian Follow‐Up Study. 54
Anedonia ed ideazione suicidaria in giovani all'esordio psicotico: risultati dal mondo reale 52
Mental health interventions in an Italian prison: the Parma integrated approach 51
Adverse outcome analysis in people at clinical high risk for psychosis: results from a 2‑year Italian follow‑up study. 51
Borderline personality disorder vs. mood disorders: clinical comparisons in young people treated within an “Early Intervention” service for first episode psychosis. 48
Characterization of young people with first episode psychosis or at ultra-high risk: The Reggio Emilia At-Risk Mental States (ReARMS) program 48
Budget di salute all’esordio psicotico. 48
The Italian Version of the Brief 21-Item Prodromal Questionnaire: Field Test, Psychometric Properties and Age-Sensitive Cut-Offs 47
Disorganization in early psychosis: historical and clinical considerations 46
Working alliance in treating staff and patients with Schizophrenia Spectrum Disorder living in Residential Facilities. 43
Baseline antipsychotic prescription and short-term outcome indicators in individuals at clinical high-risk for psychosis: Findings from the Parma At-Risk Mental States (PARMS) program. 41
Personal health budget in patients with first episode psychosis: A new rehabilitation model based on a community care system in Italy 41
Aberrant salience in first-episode psychosis: Longitudinal stability and treatment-response 41
Identifying adolescents in the early stage of psychosis: A screening checklist for referrers 40
Anhedonia in adolescents at ultra-high risk (UHR) of psychosis: findings from a 1-year longitudinal study 40
The “Parma—Early Psychosis” program: General description and process analysis after 5 years of clinical activity 40
Adolescents at ultra-high risk of psychosis in Italian neuropsychiatry services: prevalence, psychopathology and transition rate 39
Anhedonia in the psychosis risk syndrome: State and trait characteristics 39
Subgroups of Clinical High Risk for Psychosis Based on Baseline Antipsychotic Exposure: Clinical and Outcome Comparisons Across a 2-Year Follow-up Period 39
Overcoming the gap between child and adult mental health services: The Reggio Emilia experience in an early intervention in psychosis program 39
Association between psychosocial interventions and aberrant salience in adolescents with early psychosis: A follow-up study 39
Suicidal thinking and behaviours in First Episode Psychosis: Findings from a 3-year longitudinal study 38
Subjective experience of aberrant salience in young people at Ultra-High Risk (UHR) for psychosis: a cross-sectional study 38
Negative symptom dimensions in first episode psychosis: Is there a difference between schizophrenia and non-schizophrenia spectrum disorders? 38
Subjective language disturbances in young patients at ultra-high risk for psychosis (UHR): what relevance for clinical prognosis? A 2-year follow-up study. 38
Suicide risk in young people at Ultra -High Risk (UHR) of psychosis: Findings from a 2-year longitudinal study 37
A 2-year longitudinal study on subjective experience of social cognition in young people with first episode psychosis 36
Psychiatric Antecedents in Adolescents at Clinical High Risk for Psychosis: Insights from the “Parma At-Risk Mental States” Follow-up Program 36
Anhedonia in young people with first episode psychosis: a longitudinal study 36
Anhedonia in schizophrenia 35
Subjective experience of social cognition in adolescents at ultra-high risk of psychosis: findings from a 24-month follow-up study 35
Anhedonia in schizophrenia and major depression: State or trait? Review of the literature 35
Validation of the “early detection Primary Care Checklist” in an Italian community help-seeking sample: The “checklist per la Valutazione dell'Esordio Psicotico” 34
Subjective experience of social cognition in young people at Ultra-High Risk of psychosis: a 2-year longitudinal study 34
Longitudinal evaluation on negative symptoms in young people at Ultra‑High Risk (UHR) of psychosis: results from a 2‑year follow‑up study in a real‑world care setting 34
Suicide risk in young people at Ultra-High Risk (UHR) of psychosis: Findings from a 2-year longitudinal study 34
Disorganization in first episode schizophrenia: Treatment response and psychopathological findings from the 2-year follow-up of the “Parma Early Psychosis” program 33
Examining subjective experience of aberrant salience in young individuals at ultra-high risk (UHR) of psychosis: A 1-year longitudinal study 33
Simple schizophrenia: Modernity of Eugen Bleuler's thinking 33
Individual placement and support in Italian young adults with mental disorder: Findings from the Reggio Emilia experience 32
Mental health interventions in Italian prisons: are we ready for a new model? Suggestions from the Parma experience. 31
Suicidality in youths at clinical high risk for psychosis: a neglected public health concern. 31
Examining subjective experience of social cognition in early psychosis: Validation of the Italian version of the GEOPTE scale in an adolescent and young adult clinical sample 31
Validation of the Italian version of the Davos Assessment of Cognitive Biases Scale (DACOBS) in a sample of schizophrenia spectrum disorder patients and healthy controls 31
Anhedonia in schizophrenia and major depression: State or trait? 31
Clinical high risk for psychosis in childhood and adolescence: findings from the 2-year follow-up of the ReARMS project 30
Suicidal Ideation in Patients Experiencing a First-episode Psychosis: Findings From the 2-Year Follow-up of the “Parma Early Psychosis” Program 29
Anhedonia in schizophrenia and major depression: state or trait? 29
Clozapine-induced intestinal occlusion: A serious side effect 28
Suicidal thinking and behavior in young people at Clinical High Risk for Psychosis: Psychopathological considerations and treatment response across a 2-year follow-up study 28
Association between case management and longitudinal decrease in negative symptoms in patients with first episode psychosis: A 2-year follow-up 28
The "Parma At-Risk mental states" (PARMS) program: General description and process analysis after 5 years of clinical activity. 28
Totale 7.129
Categoria #
all - tutte 26.192
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.192


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023405 0 0 0 0 0 0 118 21 142 21 45 58
2023/2024630 3 94 58 43 52 61 45 52 37 70 59 56
2024/20253.308 94 233 272 252 530 173 118 112 78 151 397 898
2025/20263.823 550 984 709 705 626 249 0 0 0 0 0 0
Totale 8.166